Cargando…

Fingolimod promotes blood–nerve barrier properties in vitro

OBJECTIVE: The main effect of fingolimod is thought to be functional antagonism of lymphocytic S1P1 receptors and the prevention of lymphocyte egress from lymphoid tissues, thereby reducing lymphocyte infiltration into the nervous system. However, a growing number of reports suggest that fingolimod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishihara, Hideaki, Maeda, Toshihiko, Sano, Yasuteru, Ueno, Maho, Okamoto, Nana, Takeshita, Yukio, Shimizu, Fumitaka, Koga, Michiaki, Kanda, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893339/ https://www.ncbi.nlm.nih.gov/pubmed/29670818 http://dx.doi.org/10.1002/brb3.924

Ejemplares similares

Fingolimod Prevents Blood-Brain Barrier Disruption Induced by the Sera from Patients with Multiple Sclerosis
por: Nishihara, Hideaki, et al.
Publicado: (2015)

Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica
por: Shimizu, Fumitaka, et al.
Publicado: (2015)

Autocrine TNF-α Increases Penetration of Myelin-Associated Glycoprotein Antibodies Across the Blood-Nerve Barrier in Anti-MAG Neuropathy
por: Sato, Ryota, et al.
Publicado: (2023)

Severity and Patterns of Blood-Nerve Barrier Breakdown in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Correlations with Clinical Subtypes
por: Shimizu, Fumitaka, et al.
Publicado: (2014)

Sera from Remitting and Secondary Progressive Multiple Sclerosis Patients Disrupt the Blood-Brain Barrier
por: Shimizu, Fumitaka, et al.
Publicado: (2014)

GRP 78 antibodies are associated with clinical phenotype in neuromyelitis optica
por: Shimizu, Fumitaka, et al.
Publicado: (2019)

Jo-1 Antibodies From Myositis Induce Complement-Dependent Cytotoxicity and TREM-1 Upregulation in Muscle Endothelial Cells
por: Honda, Masaya, et al.
Publicado: (2023)

GRP78 Antibodies Are Associated With Blood-Brain Barrier Breakdown in Anti–Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disorder
por: Shimizu, Fumitaka, et al.
Publicado: (2021)

Effects of neuromyelitis optica–IgG at the blood–brain barrier in vitro
por: Takeshita, Yukio, et al.
Publicado: (2016)

Blood–Nerve Barrier (BNB) Pathology in Diabetic Peripheral Neuropathy and In Vitro Human BNB Model
por: Takeshita, Yukio, et al.
Publicado: (2020)

Advancing human induced pluripotent stem cell‐derived blood‐brain barrier models for studying immune cell interactions
por: Nishihara, Hideaki, et al.
Publicado: (2020)

Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
por: Spampinato, Simona F., et al.
Publicado: (2015)

New BBB Model Reveals That IL-6 Blockade Suppressed the BBB Disorder, Preventing Onset of NMOSD
por: Takeshita, Yukio, et al.
Publicado: (2021)

Antineutrophil cytoplasmic antibody-associated vasculitis with predominant truncal muscle weakness: a retrospective case series
por: Nemoto, Joe, et al.
Publicado: (2023)

Development of a human in vitro blood–brain tumor barrier model of diffuse intrinsic pontine glioma to better understand the chemoresistance
por: Deligne, Clémence, et al.
Publicado: (2020)

Contribution of brain pericytes in blood–brain barrier formation and maintenance: a transcriptomic study of cocultured human endothelial cells derived from hematopoietic stem cells
por: Heymans, Marjolein, et al.
Publicado: (2020)

A perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport
por: Wevers, Nienke R., et al.
Publicado: (2018)

Decreased Astrocytic CCL2 Accounts for BAF-312 Effect on PBMCs Transendothelial Migration Through a Blood Brain Barrier in Vitro Model
por: Spampinato, Simona F., et al.
Publicado: (2021)

Fingolimod increases parvalbumin-positive neurons in adult mice
por: Ueno, Hiroshi, et al.
Publicado: (2022)

Autopsy case of the C12orf65 mutation in a patient with signs of mitochondrial dysfunction
por: Nishihara, Hideaki, et al.
Publicado: (2017)

Serotonin/5-HT1A Signaling in the Neurovascular Unit Regulates Endothelial CLDN5 Expression
por: Sugimoto, Kotaro, et al.
Publicado: (2020)

Secretome of endothelial progenitor cells from stroke patients promotes endothelial barrier tightness and protects against hypoxia-induced vascular leakage
por: Loiola, Rodrigo Azevedo, et al.
Publicado: (2021)

Reciprocal Interplay Between Astrocytes and CD4+ Cells Affects Blood-Brain Barrier and Neuronal Function in Response to β Amyloid
por: Spampinato, Simona Federica, et al.
Publicado: (2020)

Astrocytes Modify Migration of PBMCs Induced by β-Amyloid in a Blood-Brain Barrier in vitro Model
por: Spampinato, Simona Federica, et al.
Publicado: (2019)

Fingolimod promotes peripheral nerve regeneration via modulation of lysophospholipid signaling
por: Szepanowski, Fabian, et al.
Publicado: (2016)

Determination of Seminal Concentration of Fingolimod and Fingolimod‐Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod
por: David, Olivier J., et al.
Publicado: (2017)

Pioglitazone Attenuates the Effects of Peripheral Inflammation in a Human In Vitro Blood–Brain Barrier Model
por: da Rocha, Gustavo Henrique Oliveira, et al.
Publicado: (2022)

Fingolimod (FTY720-P) Does Not Stabilize the Blood–Brain Barrier under Inflammatory Conditions in an in Vitro Model
por: Schuhmann, Michael K., et al.
Publicado: (2015)

Fingolimod-induced decrease in heart rate may predict subsequent decreasing degree of lymphocytes
por: Ikeda, Tokunori, et al.
Publicado: (2018)

Cognitive Impairment Caused by Isolated Adrenocorticotropic Hormone Deficiency without Other Hypo-adrenalism Signs - Autoimmune Encephalopathy Mimics
por: Matsuo, Kinya, et al.
Publicado: (2019)

Neuroprotective Effects of Fingolimod Supplement on the Retina and Optic Nerve in the Mouse Model of Experimental Autoimmune Encephalomyelitis
por: Yang, Tao, et al.
Publicado: (2021)

Antidepressant activity of fingolimod in mice
por: di Nuzzo, Luigi, et al.
Publicado: (2015)

Fingolimod for Irradiation-Induced Neurodegeneration
por: Metzdorf, Judith, et al.
Publicado: (2019)

Modulation of Cardiac Autonomic Function by Fingolimod Initiation and Predictors for Fingolimod Induced Bradycardia in Patients with Multiple Sclerosis
por: Li, Kai, et al.
Publicado: (2017)

Author Correction: Fingolimod-induced decrease in heart rate may predict subsequent decreasing degree of lymphocytes
por: Ikeda, Tokunori, et al.
Publicado: (2019)

Antecedent infections in Fisher syndrome: sources of variation in clinical characteristics
por: Koga, Michiaki, et al.
Publicado: (2019)

Neurological safety of fingolimod: An updated review
por: Yoshii, Fumihito, et al.
Publicado: (2017)

Design and Validation of a Human Brain Endothelial Microvessel-on-a-Chip Open Microfluidic Model Enabling Advanced Optical Imaging
por: Salman, Mootaz M., et al.
Publicado: (2020)

Intermittent Atrioventricular Block following Fingolimod Initiation
por: Gialafos, E., et al.
Publicado: (2014)

Vagomimetic Effects of Fingolimod: Physiology and Clinical Implications
por: Vanoli, Emilio, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_54tplpue0iua6882mm7ssr767l